As David L. Carr-Locke, MD, sees it, the identification of a previously unknown anatomical structure in the human body harkens back to the medical discoveries of centuries past.

The primary goal of the study is to see whether adding radiation therapy to an intensive chemotherapy regimen will improve the survival rate of patients with borderline resectable pancreatic cancer.

A physician-scientist at NewYork-Presbyterian/Columbia has set her sights on applying the discoveries made in her lab to improve tissue healing and treatment for the many diseases that can affect the gut.

The DiLumen Endolumenal Interventional Platform (EIP) developed at NewYork-Presbyterian/Weill Cornell is paving the way for dramatic changes in the treatment of many intestinal diseases.

While the use of fecal material as a medical remedy dates back to the fourth century, usage waned. In recent years, fecal microbiota transplant to control multiple relapses of Clostridium difficile infections is rising.

The Pancreatic Cyst Surveillance Program at NewYork-Presbyterian/Columbia helps identify patients with pancreatic cysts who are at risk for developing cancer and those who are not.